UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017119
Receipt number R000019756
Scientific Title Menatetrenone Intervention for Dialysis Patients with ArterioSclerosis
Date of disclosure of the study information 2015/04/15
Last modified on 2017/07/11 14:59:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Menatetrenone Intervention for Dialysis Patients with ArterioSclerosis

Acronym

MIDAS study

Scientific Title

Menatetrenone Intervention for Dialysis Patients with ArterioSclerosis

Scientific Title:Acronym

MIDAS study

Region

Japan


Condition

Condition

Patients with chronic kidney disease

Classification by specialty

Medicine in general Nephrology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Influence of vitamin K treatment on bone, frailty, and vascular change

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Bone mineral density, vascular calcification , frailty, and prognosis

Key secondary outcomes

Oxidative stress: malondialdehyde, 8OHdG, AOPP, pentosidine, GSH. inflammation: high-sensitivity CRP, IL-6, TNF, pentraxin, troponin T. nutrition: BMI, albumin et al.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

With vitamin K (menatetrenone 45 mg)

Interventions/Control_2

Without vitamin K

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

Patients on maintenance hemodialysis without iron deficiency anemia

Key exclusion criteria

Receiving warfarin, pregnacy, hypersensitivity, liver dysfunction, thrombosis

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Nakanishi

Organization

Hyogo College of Medicine

Division name

Dep Internal Medicine, Div Kidney and Dialysis

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6521

Email

jin@hyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukiko Hasuike

Organization

Hyogo College of Medicine

Division name

Dep Internal Medicine, Div Kidney and Dialysis

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya, Hyogo

TEL

0798-45-6521

Homepage URL


Email

cherry39@hyo-med.ac.jp


Sponsor or person

Institute

Hyogo College of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hyogo College of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Meiwa hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

兵庫医科大学(兵庫県),明和病院(兵庫県)


Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2015 Year 04 Month 03 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 15 Day

Last follow-up date

2017 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 04 Month 13 Day

Last modified on

2017 Year 07 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019756


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name